Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
mRNA-1273 SARS-CoV-2-vaccin 94,1% werkzaam
feb 2021 | Vaccinatie, Virale infecties